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Kimura disease (KD) is an eosinophilic, granulomatous, benign, chronic inﬂamma-
tory disease with an unknown etiology. A 33-year-old woman visited our hospital
because of a palpable, left subclavian mass, a left scapulo-anterior pseudoaneurysm,
and nephrotic syndrome. Her subclavian lymph node biopsy examination result was
consistent with KD, and results of a renal biopsy indicated secondary membranous
nephropathy. After renal histological examination conﬁrmed nephropathy, treat-
ment with prednisolone and cyclosporine was initiated, which was maintained
for over 1 year. However, this therapy only provided a transient improvement
in proteinuria. One year after commencing the treatment, both proteinuria and
azotemia aggravated as the left axillary mass doubled in size. Finally, the mass was
surgically excised, following which the azotemia rapidly normalized and proteinuria
resolved within 1 month. This case shows that tumor resection in a patient with KD
with secondary nephropathy may resolve secondary renal manifestations. Further-
more, reversible renal dysfunction may be caused by unknown secreted molecules.
& 2014. The Korean Society of Nephrology. Published by Elsevier. This is an open
access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Kimura disease (KD) presents as a subcutaneous mass, most
frequently occurring in the head and neck regions. The disease
is characterized by a benign, angiolymphomatous proliferation
with eosinophilic inﬁltration. The histological characteristics of
the disease are hyperplastic lymphoid tissue that contains
well-developed lymphoid follicles, marked inﬁltration of
eosinophils, vascular proliferation, and ﬁbrosis. It is also
associated with the development of renal disease, especially
nephrotic syndrome [1]. Previously, surgical resection was the
treatment of choice. However, treatments with steroid andn Society of Nephrology. Publi
c-nd/4.0/).
y, Department of Internal
01 Daehak-ro, Jongno-gu,immunosuppressive agents were also reported to produce
beneﬁcial effects [2], although discontinuation of steroid often
results in recurrence of the masses [3]. In patients with renal
manifestations, however, surgical resection is usually not the
ﬁrst-choice treatment. We herein report the case of secondary
membranous nephropathy (MN) associated with KD which
recovered after surgical resection of the mass.Case report
A 33-year-old woman presented with a soft-tissue mass in
her left axillary area. A percutaneous biopsy was performed,
and histological ﬁndings showed atypical lymphoid hyperpla-
sia with many eosinophilic inﬁltrations, which are consistent
with KD (Fig. 1). Neither proteinuria nor hypereosinophilia was
noted. One-month treatment with oral prednisolone could notshed by Elsevier. This is an open access article under the CC BY-NC-ND
Figure 1. Left subclavian mass consistent with Kimura disease. (A) A left scapulo-anterior pseudoaneurysm in the left axillary area (arrow). Light
microscopic images of hematoxylin and eosin–stained sections of the subclavian lymph node biopsy specimen show (B) a well-developed lymphoid
follicle with eosinophilic inﬁltration and (C) vascular proliferation (200 ).
Figure 2. Renal biopsy specimens diagnosed with membranous nephropathy. (A) Light microscopic image of a biopsy specimen shows
hypercellular mesangial cells (Hematoxylin and eosin-stained, 200 ). (B) An electron microscopic image of a similar specimen reveals electron-
dense deposits in some subepithelial areas and diffuse foot process effacement (20,000 ). Using immunoﬂuorescence microscopy, granular deposits
of (C) IgG, 3þ , (D) IgM, 2þ , (E) C3, 3þ , and (F) C1q, 1þ were detected in the mesangium (400 ). Ig, immunoglobulin.
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6-cm, left scapulo-anterior pseudoaneurysmwas noted (Fig. 1),
which required a stent-graft insertion. Following the graft
insertion, the size of pseudoaneurysm decreased. Hypereosino-
philia (12,450/mm3) was noted during this period. Treatment
with prednisolone was continued for 1 year, and eosinophilia
gradually improved too500/mm3 within this period.
One and half year after the diagnosis of KD, the patient
presented with a month-long history of foamy urine and a
weight gain of 5 kg; pitting edema of both lower extremities
was also observed.
Upon admission, the patient’s blood pressure was 98/
61 mmHg, white blood cell (WBC) count was 7,200/mm3 (with
33.8% eosinophils), and hemoglobin and platelet levels were
14.5 g/dL and 287,000/mm3, respectively. Serum blood urea
nitrogen and creatinine levels were within the normal range,
with a creatinine clearance rate of 120 mL/min/1.73 m2. Other
laboratory assessments showed normal electrolyte, low serum
albumin (1.3 g/dL), and high cholesterol (521 mg/dL) levels;
complement proteins (C3 and C4) and immunoglobulins (Ig) A,G, and M were within normal limits. The patient’s virology
proﬁle was negative for hepatitis B and C, and her immunologic
status was negative for anti-double-stranded DNA, antistrepto-
coccal antibodies, cryoglobulins, and rheumatoid factor. Urina-
lysis was 4þ positive for protein, with ﬁve to six red blood cells
and ﬁve to nine WBCs per high-power ﬁeld. The random, spot
urinary protein-to-creatinine ratio (uPCR) was 16.6 g/g, and
urine protein electrophoresis showed nonspeciﬁc proteinuria.
A light microscopic examination of renal biopsy specimens
showed diffuse thickening of the capillary walls, focal, mild
hypercellular mesangial cells, and normal-sized glomeruli. An
electron microscopic examination revealed electron-dense
deposits in some subepithelial areas and diffuse foot process
effacement. An immunoﬂuorescence microscopic examination
revealed granular deposits of IgM, IgG, C3, and C1q in
the mesangium (Fig. 2). Overall, the MN was diagnosed as
Ehrenreich and Churg Stage III. Angiotensin receptor blocker or
angiotensin-converting enzyme inhibitor was considered the
ﬁrst-choice treatment. However, the patient’s blood pressure
was too low to add antihypertensive drugs to the treatment
Figure 3. Serum creatinine and random urinary protein-to-creatinine
ratio (uPCR) over time. Initial treatment with cyclosporine and predniso-
lone (Pd) resulted in transient proteinuria improvement. However, surgical
resection of the left subclavian mass was followed by recovery of renal
function. The solid line represents serum creatinine levels (mg/dL), whereas
the dashed line represents the random uPCR (g/g). KD, Kimura disease.
Lee et al / Remission of MN in Kimura disease 159protocol. The proteinuria slowly resolved (from 16.6 g/g/d to
2.0 g/g/d) over a 6-month period upon treatment with cyclos-
porine (3.5 mg/kg/d) and prednisolone (dose tapered from
0.5 mg/kg/d to 0.17 mg/kg/d within 6 months). However,
1.5 years from the onset of nephrotic syndrome, the patient’s
random uPCR and serum creatinine level increased
to 31.0 g/g and 2.11 mg/dL, respectively. Fractional sodium
excretion was calculated to be 1.23%. Moreover, at the same
time, the left subclavian mass had enlarged from an initial
5.8 cm3.6 cm to 7.2 cm 7.2 cm, causing occlusion of the
left axillary artery. Therefore, surgical resection was necessary,
and pathological reports of the excised specimen were con-
sistent with KD.
Fortunately, after the mass excision, the azotemia normal-
ized from a serum creatinine level of 2.11 mg/dL to 1.11 mg/dL,
and proteinuria resolved from a random uPCR of 31.0 g/g
to 6.9 g/g within 1 month. After 3 months of follow up, the
patient’s serum creatinine level was 0.68 mg/dL, and the
random uPCR was 2.78 g/g (Fig. 3).Discussion
KD often follows a benign, chronic course but does not
generally resolve spontaneously and shows frequent relapses.
Although most patients do not have systemic symptoms,
12–16% of these patients have nephropathy that often presents
as nephrotic syndrome [2].
Although the pathogenesis of renal involvement and
vasculitis in KD is unclear, several immunopathogenetic fea-
tures have been suggested. Katagiri et al [4] showed that
elevated tumor necrosis factor-α, interleukin (IL)-4, IL-5, and
IL-13 are found in the peripheral blood cells of KD patients, as
well as in the lesion tissue. This observation supports the fact
that T-helper 2 (Th2) cytokines play a part in the development
of KD [5]. In addition, Lu et al [6] reported a case of KD
secondary to chronic renal graft failure. Because chronic graft
rejection is considered to be induced by Th2 cell-produced ILs,
Th2 cytokines and overgrowth of the CD4þ Th2 may play an
important role in KD.Many treatment methods were proposed for KD, including
corticosteroid, cyclosporine, surgical excision, and radiother-
apy (RT). Corticosteroids were reported to be effective in
controlling KD. This implies that T-cell- mediated pathogenesis
maybe involved in KD since corticosteroids are known to
regulate T-cell proliferation and lymphokine production. How-
ever, recurrence upon termination of steroid therapy was
reported in 15–40% of the patients. Recent reports suggest
that immunosuppressants such as cyclosporine and vincristine
reduce recurrence rate [7,8]. Katagiri et al [4] reported on
the effectiveness of cyclosporine (4 mg/kg/d for 3 months
followed by 3.5 mg/kg/d for 6 months) in treating KD.
A previous study showed that RT is more effective than local
excision and steroid therapy for the treatment of KD. With the
65-month median follow-up duration, local control was
achieved in nine (64.3%) of the 14 patients in the RT group
and in two (22.2%) of the nine patients in the non-RT group [9].
For local mass control, surgery is often recommended as
the ﬁrst-choice treatment [10]. However, the role of surgical
resection in controlling renal manifestations in patients with
KD has not yet been clariﬁed. This case showed that surgical
resection resulted in reversal of not only azotemia but
also proteinuria. A similar reversal case was reported pre-
viously with regard to Castleman’s disease. A patient with a
mixed type of localized Castleman’s disease complicated
with nephrotic syndrome underwent removal of two mesen-
teric lymphoid masses. After the surgical resection, the
proteinuria gradually decreased and disappeared [11]. In
patients with Castleman’s disease having renal complica-
tions, immunosuppressants such as prednisolone and
azathioprine are often used [12], similar to the treatment
for KD. However, surgical resection is helpful to reverse the
renal function.
Both KD and Castleman’s disease cases imply that some
unknown circulating mediators secreted by the primary tumor
may cause renal dysfunction. It has long been postulated that
some circulating humoral factors might cause proteinuria in
minimal change nephrotic syndrome (MCNS) and focal seg-
mental glomerulosclerosis (FSGS) [13]. A T-cell-derived
humoral factor might induce damages to the glomerular
permeability barrier in MCNS. Hemopexin is one of the
proposed molecules, which can cause proteinuria and glomer-
ular alterations characteristic of MCNS [14]. In cases with FSGS,
post-transplant recurrence of proteinuria and its response to
plasmapheresis suggest the role of some plasma factors.
Soluble urokinase receptor is detected in the plasma of
patients with recurrent FSGS, and this can induce foot
process effacement, proteinuria, and FSGS-like glomerulopa-
thy [15].
In our patient, surgical mass reduction induced reversal
of not only proteinuria but also the serum creatinine level.
Although the patient’s serum creatinine level gradually
increased over a 2-year period, the estimated glomerular
ﬁltration rate was fully normalized after surgical mass reduc-
tion. This suggests that renal dysfunction in this patient is
possibly caused by a reversible mechanism. We can postulate
that unknown circulating factors secreted by the angiolym-
phoid hyperplastic mass persistently restrict glomerular ﬁltra-
tion possibly without evident chronic damage. Because
proteinuria slowly improved compared with the serum crea-
tinine level, some humoral factors might have induced struc-
tural change to the glomerular permeability barrier so that it
took more time to recover.
Kidney Res Clin Pract 33 (2014) 157–160160We described the ﬁrst ofﬁcial case of secondary MN in a KD
patient in Korea. Moreover, renal complications in this patient
were nearly normalized after surgical mass reduction. This
suggests that surgical resection could be preferentially be
considered prior to medical treatment in KD patients with
renal complications.Conﬂict of interest
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